Toolkits
Our toolkits were developed to help you with your opioid use disorder practice. They are guides to help you address a range of topics.
-
Where to Obtain Naloxone (Updated November 2022) for print use
NJ Senate & Assembly Syringe Access Expansion Laws
Harm Reduction Education Materials (Updated October 2021)
Harm Reduction Guide (Updated August 2021)
The War on Drugs: Shaping our Perspective of Patients Who Use Drugs (part 1) (Updated May 2021)
The War on Drugs: Shaping our Perspective of Patients Who Use Drugs (part 2) (Updated May 2021)
Principles of Harm Reduction(Updated 2020)
-
Amerigroup OBAT Attestation
-
Using Injectable Buprenorphine (Sublocade) Booklet (Updated April 2022) for print use
Using Injectable Buprenorphine (Sublocade) Infographic (Updated April 2022) for digital or print use
Diverted “Extramedical” Use of Buprenorphine Brochure (Updated January 2022) for print use
Buprenorphine Home Induction Handout (Updated November 2021) for digital or print use
PCSS Implementation Needs Assessment Document (Updated 2021)
National Institute on Drug Abuse Medication Infographic (Updated 2021)
NJMATCOE Emergency Department Buprenorphine Bridge Materials (Updated August 2021)
Buprenorphine Waiver Tip Sheet (Updated June 2021)
ASAM National Practice Guideline – Part 1 (Updated 2020)
ASAM National Practice Guideline – Part 2 (Updated 2020)
ASAM National Practice Guideline – Part 3 (Updated 2020)
DEA Requirements for Medication Storage Module (Updated July 2020)
-
A Patent’s Guide to Precipitated Withdrawal (Updated February 2023) for print use
Loss of Tolerance after Periods of Abstinence Booklet (Updated November 2022) for print use
Injectable Buprenorphine FAQ Booklet (Updated September 2022) for print use
Injectable Buprenorphine FAQ Infographic (Updated September 2022) for digital or print use
-
The War on Drugs: Shaping our Perspectives of Patients who Use Drugs – Part 1 (Updated 2021)
The War on Drugs: Shaping our Perspectives of Patients who Use Drugs – Part 2 (Updated 2021)
DEA Drugs of Abuse Report – Part 1 (Updated 2020)
DEA Drugs of Abuse Report – Part 2 (Updated 2020)
Innovative Practices Module (Updated August 2020)